Effects of Levonorgestrel IUD on Hemoglobin, Quality of Life, and Polyp Recurrence in Heavy Menstrual Bleeding


Kucukyurt A. K., Kolcu S. A., Ozturk B., Kara E., İLHAN G.

Journal of Obstetrics and Gynecology of India, 2026 (ESCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s13224-026-02416-5
  • Dergi Adı: Journal of Obstetrics and Gynecology of India
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, Health Research Premium Collection (ProQuest)
  • Anahtar Kelimeler: Endometrium, Heavy menstrual bleeding, LNG-IUD, Polyp
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: Endometrial polyps (EP) are a common cause of heavy menstrual bleeding (HMB). While Levonorgestrel-releasing intrauterine devices (LNG-IUDs) are effective for HMB control, their impact on EP recurrence and subsequent patient-reported outcomes, such as quality of life, remains a subject of investigation. Aim: To evaluate the effect of LNG-IUD on symptom control, health-related quality of life (QoL), and EP recurrence in patients with HMB who were diagnosed with EP following dilatation and curettage (D&C). Materials and Methods: This retrospective cohort study included 69 women who presented with HMB and were diagnosed with EP on histopathology after D&C. Following D&C, all patients received an LNG-IUD. Symptoms and QoL were assessed using the Menorrhagia Multi-Attribute Scale (MMAS) and the Medical Outcomes Study 36-Item Short Form Health Survey (MOS SF-36) at baseline and at 6 and 12 months. Patients were stratified into groups with and without polyp recurrence, as determined by follow-up ultrasonography. Results: Over the 12-month follow-up period, the polyp recurrence rate was 14.5% (n = 10). Hemoglobin (Hb) levels significantly improved in both the recurrence and non-recurrence groups. However, significant improvements in MMAS and SF-36 scores were observed only in the non-recurrence group (p < 0.05), with no significant change detected in the recurrence group. Conclusion: LNG-IUD is effective for HMB control (Hb improvement) regardless of recurrence. Crucially, the full benefit of LNG-IUD on patient-reported QoL and treatment adherence is contingent upon the prevention of EP recurrence. These findings highlight the importance of recurrence-free status for achieving optimal patient outcomes.